Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapyRakesh K. Jain(Harvard University)Nature MedicineSeptember 1, 200110.1038/nm0901-987Cited by 2,165SaveCiteExport RISWatch citationsAbstractRelated PapersAngiogenesis in cancer and other diseasesPeter Carmeliet, Rakesh K. Jain|Nature|2000|9kGenes Expressed in Human Tumor EndotheliumBrad St. Croix, Carlo Rago, Victor E. Velculescu et al.|Science|2000|1.8kAntiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.Timothy M. Browder, Catherine Butterfield, Birgit M. Kräling et al.|PubMed|2000|1.6kSelective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalLaura E. Benjamin, Dragan Golijanin, Ahuva Itin et al.|Journal of Clinical Investigation|1999|1.2kContinuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicityGiannoula Klement, Sylvain Baruchel, Janusz Rak et al.|Journal of Clinical Investigation|2000|1.2k